[HTML][HTML] SARS-CoV-2 vaccines and autoimmune diseases amidst the COVID-19 crisis

T Velikova, T Georgiev - Rheumatology international, 2021 - Springer
Abstract Coronavirus disease 2019 (COVID-19) pandemic has become challenging even for
the most durable healthcare systems. It seems that vaccination, one of the most effective …

[HTML][HTML] COVID-19 and the clinical course of rheumatic manifestations

S Ahmed, O Zimba, AY Gasparyan - Clinical rheumatology, 2021 - Springer
The manifestations of COVID-19 have been evolving over time. Various post-COVID-19
syndromes are being recognised. Various viruses have been implicated in the pathogenesis …

Outcomes of COVID-19 in patients with rheumatoid arthritis: a multicenter research network study in the United States

R Raiker, C DeYoung, H Pakhchanian, S Ahmed… - Seminars in arthritis and …, 2021 - Elsevier
Objectives To investigate outcomes of Coronavirus Disease-2019 (COVID-19) in patients
with rheumatoid arthritis (RA) as compared to the general population. Additionally, outcomes …

[HTML][HTML] Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews

F Karaarslan, F Demircioğlu Güneri… - Rheumatology …, 2021 - Springer
To describe the rheumatic and musculoskeletal symptoms at hospitalization as well as their
persistence/severity after discharge with coronavirus disease 2019 (COVID-19) and to …

[HTML][HTML] Reactive arthritis after COVID-19: a case-based review

BF Kocyigit, A Akyol - Rheumatology international, 2021 - Springer
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the coronavirus disease 19 (COVID-19) pandemic, which is deeply affecting the whole …

[HTML][HTML] Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey

S Cherian, A Paul, S Ahmed, B Alias, M Manoj… - Rheumatology …, 2021 - Springer
Patients with rheumatic and musculoskeletal (RMD) diseases may be at higher risks for
COVID-19 infection. Data on the safety of the adenoviral vector-borne ChAdOx1 nCoV-19 …

[HTML][HTML] Immunogenicity, effectiveness, and safety of COVID-19 vaccines in rheumatic patients: an updated systematic review and meta-analysis

KT Tang, BC Hsu, DY Chen - Biomedicines, 2022 - mdpi.com
Background: Vaccination is one of the most important measures worldwide to halt the
spread of the corona virus disease 2019 (COVID-19). However, the efficacy and safety of …

[HTML][HTML] Increased risk of mental health disorders in patients with RA during the COVID-19 pandemic: a possible surge and solutions

A Bhatia, M Kc, L Gupta - Rheumatology international, 2021 - Springer
Depression is a common co-morbidity among rheumatoid arthritis (RA) patients, which may
translate into difficulty performing activities of daily living. COVID-19 is an unprecedented …

Diabetes mellitus in rheumatic diseases: clinical characteristics and treatment considerations

Y Fedorchenko, K Mahmudov, Z Abenov… - Rheumatology …, 2023 - Springer
New pathophysiological insights are now available on comorbidities in rheumatic diseases
(RDs). Several nationwide studies point to the fact that comorbid diabetes mellitus (DM) …

[HTML][HTML] Interferon-gamma release assays outcomes in healthy subjects following BNT162b2 mRNA COVID-19 vaccination

E Kurteva, G Vasilev, K Tumangelova-Yuzeir… - Rheumatology …, 2022 - Springer
The pathogenesis of COVID-19 involves both humoral and cellular immunological
responses, with cell-mediated immunity being discussed as the primary and most effective …